Imipenem pharmacokinetics. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms15

Pseudomonas aeruginosa Acinetobacter baumannii Acinetobacter Gram-Negative Bacteria Bacteroides fragilis Klebsiella pneumoniae Bacteria, Anaerobic Enterobacteriaceae Gram-Positive Bacteria Enterobacter cloacae Enterobacter Rats, Sprague-Dawley Bacteria Staphylococcus aureus Macaca fascicularis

Diseases13

Acinetobacter Infections Pseudomonas Infections Gram-Negative Bacterial Infections Enterobacteriaceae Infections Bacterial Infections Klebsiella Infections Neoplasms Cross Infection Pneumonia, Bacterial Bacteroides Infections Bacteremia Gram-Positive Bacterial Infections Neutropenia

Chemicals and Drugs68

Imipenem Thienamycins Cilastatin Anti-Bacterial Agents Carbapenems beta-Lactamases Ceftazidime Cephalosporins Sulbactam Piperacillin Amikacin Cyclopropanes Lactams Dipeptidases Anti-Infective Agents Ciprofloxacin Aztreonam Drug Combinations Penicillanic Acid Cefotaxime Colistin Fluoroquinolones Moxalactam Cefoperazone Cytochrome P-450 CYP3A Penicillin-Binding Proteins Prodrugs Netilmicin Gentamicins Nafcillin Tobramycin Cefotiam Ceftriaxone Porins Muramoylpentapeptide Carboxypeptidase Cephalosporinase Vancomycin Hexosyltransferases Cefmetazole Penicillins Ritonavir Peptidyl Transferases Rifampin Cefoxitin Ampicillin Minocycline Quinolines Bacterial Proteins Quinolones Ceftizoxime Ofloxacin Antineoplastic Agents Antifungal Agents Capsules Delayed-Action Preparations Ketoconazole Clavulanic Acids Triazoles Clavulanic Acid Levofloxacin Midazolam Anti-HIV Agents Tablets Aza Compounds HIV Protease Inhibitors Aminoglycosides P-Glycoprotein Pyrimidinones

Analytical, Diagnostic and Therapeutic Techniques and Equipment23

Area Under Curve Microbial Sensitivity Tests Metabolic Clearance Rate Administration, Oral Injections, Intravenous Infusions, Intravenous Chromatography, High Pressure Liquid Cross-Over Studies Drug Therapy, Combination Drug Administration Schedule Models, Biological Injections, Intramuscular Double-Blind Method Infusions, Parenteral Treatment Outcome Drug Dosage Calculations Drug Stability Maximum Tolerated Dose Delayed-Action Preparations Injections, Subcutaneous Isoelectric Focusing Drug Monitoring Colony Count, Microbial

Phenomena and Processes20

Half-Life Area Under Curve Pharmacokinetics Metabolic Clearance Rate Biological Availability Drug Interactions Tissue Distribution Dose-Response Relationship, Drug Drug Resistance, Microbial Food-Drug Interactions Drug Resistance, Bacterial Drug Resistance, Multiple, Bacterial Kinetics Biotransformation Time Factors Maximum Tolerated Dose Therapeutic Equivalency Stereoisomerism Absorption Drug Synergism

Named Groups1

Healthy Volunteers

Health Care4

Area Under Curve Cross-Over Studies Double-Blind Method Treatment Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Named Groups Health Care

Imipenem Thienamycins Cilastatin Half-Life Area Under Curve Anti-Bacterial Agents Carbapenems Microbial Sensitivity Tests Pharmacokinetics Metabolic Clearance Rate beta-Lactamases Biological Availability Administration, Oral Injections, Intravenous Drug Interactions Ceftazidime Pseudomonas aeruginosa Infusions, Intravenous Chromatography, High Pressure Liquid Acinetobacter baumannii Cephalosporins Acinetobacter Infections Tissue Distribution Sulbactam Cross-Over Studies Piperacillin Dose-Response Relationship, Drug Amikacin Cyclopropanes Lactams Drug Resistance, Microbial Dipeptidases Food-Drug Interactions Anti-Infective Agents Drug Therapy, Combination Acinetobacter Gram-Negative Bacteria Drug Administration Schedule Ciprofloxacin Bacteroides fragilis Drug Resistance, Bacterial Aztreonam Drug Combinations Penicillanic Acid Drug Resistance, Multiple, Bacterial Pseudomonas Infections Gram-Negative Bacterial Infections Klebsiella pneumoniae Cefotaxime Bacteria, Anaerobic Kinetics Colistin Enterobacteriaceae Infections Enterobacteriaceae Biotransformation Fluoroquinolones Moxalactam Cefoperazone Cytochrome P-450 CYP3A Models, Biological Penicillin-Binding Proteins Gram-Positive Bacteria Prodrugs Netilmicin Bacterial Infections Klebsiella Infections Gentamicins Neoplasms Nafcillin Tobramycin Cross Infection Cefotiam Ceftriaxone Porins Pneumonia, Bacterial Muramoylpentapeptide Carboxypeptidase Injections, Intramuscular Enterobacter cloacae Double-Blind Method Cephalosporinase Vancomycin Hexosyltransferases Infusions, Parenteral Cefmetazole Time Factors Penicillins Ritonavir Peptidyl Transferases Rifampin Cefoxitin Ampicillin Minocycline Quinolines Treatment Outcome Bacterial Proteins Quinolones Bacteroides Infections Ceftizoxime Ofloxacin Antineoplastic Agents

No FAQ available that match "imipenem pharmacokinetics"